Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Garen Manvelian
A Phase III Randomized Trial Evaluating Alirocumab 300 Mg Every 4 Weeks as Monotherapy or Add-On to Statin: ODYSSEY CHOICE I
Atherosclerosis
Cardiovascular Medicine
Cardiology
Individualized Low-Density Lipoprotein Cholesterol Reduction With Alirocumab Titration Strategy in Heterozygous Familial Hypercholesterolemia: Results From an Open-Label Extension of ODYSSEY LONG TERM
Journal of Clinical Lipidology
Internal Medicine
Nutrition
Cardiology
Endocrinology
Cardiovascular Medicine
Dietetics
Metabolism
Diabetes
Related publications
Bevacizumab in Age-Related Macular Degeneration: A Randomized Controlled Trial on the Effect of On-Demand Therapy Every 4 or 8 Weeks
Acta Ophthalmologica
Medicine
Ophthalmology
A Phase III Randomized Controlled Trial of Tiotropium Add-On Therapy in Children With Severe Symptomatic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Low Incidence of Pneumocystis Carinii Pneumonia in HIV Patients Receiving 300 Mg Pentamidine Aerosol Every 2 Weeks
Journal of Molecular Medicine
Molecular Medicine
Drug Discovery
Genetics
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES Trial†
Journal of Clinical Lipidology
Internal Medicine
Nutrition
Cardiology
Endocrinology
Cardiovascular Medicine
Dietetics
Metabolism
Diabetes
The ODYSSEY DM-DYSLIPIDEMIA Trial: Confirming the Benefits of Alirocumab in Diabetic Mixed Dyslipidemia
Annals of Translational Medicine
Medicine
Efficacy and Safety of Alirocumab in Patients With or Without Prior Coronary Revascularization: Pooled Analysis of Eight ODYSSEY Phase 3 Trials
Atherosclerosis
Cardiovascular Medicine
Cardiology
Yoga as an Add-On Treatment in the Management of Schizophrenia: A Randomized Controlled Trial
Annals of General Psychiatry
Psychiatry
Mental Health
ACTG 260: A Randomized, Phase I-Ii, Dose-Ranging Trial of the Anti-Human Immunodeficiency Virus Activity of Delavirdine Monotherapy
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Phase III, Multicenter, Randomized, Double-Blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-Rosette (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
Clinical Therapeutics
Pharmacology
